Pj. Emmerson et al., BINDING-AFFINITY AND SELECTIVITY OF OPIOIDS AT MU-RECEPTOR, DELTA-RECEPTOR AND KAPPA-RECEPTOR IN MONKEY BRAIN MEMBRANES, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1630-1637
The binding parameters of radiolabeled DAMGO (mu), DPDPE and pCl-DPDPE
(delta) and 5 alpha, 7 alpha, 8 beta-N-methyl-N-[7-(1-pyrrolidinyl)-1
- oxaspiro(4,5)dec-8-yl]benzeneacetamide (also known as U69593, kappa)
and the affinity and selectivity profiles of various opioid agonists
and antagonists at the three opioid receptor types were determined in
membranes from brain cortex of rhesus monkey. Among the 10 opioids wit
h established mu-selective actions, etonitazene inhibited the binding
of [H-3]DAMGO with a K-i of 0.02 nM (0.01 nM without sodium) and exhib
ited mu/delta and mu/kappa selectivities of 8800 and 11,650, respectiv
ely. DAMGO had a K-i of 1.23 nM and was about 500-fold more selective
at mu receptors compared with delta and kappa sites. Other mu opioids
with higher than 100-fold binding selectivity were fentanil and sufent
anil. Highly selective delta opioids were DPDPE, deltorphin II and nal
trindole. With the exception of N,N-diallyl-Tyr-Aib-Aib-Phe-Leu-OH, al
l investigated putative delta opioids bound to delta sites with low K(
i)s, i.e., 0.04 nM, 0.13 nM and 1.4 nM for naltrindole, (+/-)-4-[(alph
a-R)-alpha-{(2S*, -piperazinyl)3-hydroxybenzyl]-N,N-diethylbenzamide
and DPDPE, respectively. In this series, the displacement of [H-3]pCl-
DPDPE yielded results similar to those obtained with [H-3]DPDPE. With
nanomolar K(i)s of 0.70, 0.89, 0.25 and 0.06, respectively, the highes
t kappa selectivity was displayed by (trans)-(+/-)-3,4-dichloro-N-meth
yl-N-[2-(1 -pyrrolidinyl)-cyclohexyl]benzeneacetamide and U69593, foll
owed by dynorphin 1-13 and norbinaltorphimine. Both ethylketocyclazoci
ne and bremazocine bound with high affinity to all three receptor type
s, showing a 15- to 127-fold preference for the kappa receptor. The bi
nding of mu-, delta-, and kappa-selective agonists and antagonists exh
ibited distinct sensitivities to sodium. The results of this study, wh
ich revealed picomolar binding affinity and receptor selectivity up to
11,600-fold in the primate brain, should aid in interpreting opioid a
ctions in vivo and in selecting receptor specific ligands to character
ize opioid receptor mechanisms in vitro.